Stopped: Study not initiated prior to enrollment.
the goal of this clinical trial is to compare in cancer patients: Is ultrasound-guided percutaneous neuromodulation useful for Anterior Knee Pain relief in cancer patients? Participants will receive treatments of ultrasound-guided percutaneous neuromodulation and pharmacological treatment Researchers will compare ultrasound-guided percutaneous neuromodulation versus pharmacological treatment to see if Anterior Knee Pain is reduced
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Numerical Pain Rating Scale (NPRS) Anterior Knee Pain changes
Timeframe: 12 weeks
Victorian Institute of Sport Assessment-Patella (VISA-P)
Timeframe: 12 weeks
The OKS (Oxford Knee Score) questionnaire for knee function.
Timeframe: 12 weeks
The Lower Limb Functional Index (LLFI).
Timeframe: 12 weeks
Borg's Rating Perceived Exertion (RPE) questionnaire for perceived fatigue.
Timeframe: 12 weeks
Pressure pain threshold
Timeframe: 12 weeks